Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew D. Ashe currently holds 342,509 shares of Verve Therapeutics, Inc. (VERV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew D. Ashe has been a net seller of VERV stock. They have purchased $604.2K and sold $2.0M worth of shares.
Andrew D. Ashe's most recent insider trade was on Jul 25, 2025, when they sold 348,828 shares at $0.00 per share.
Andrew D. Ashe serves as Executive at Verve Therapeutics, Inc. (VERV). They have executed 30 insider transactions totaling $2.6M over their tenure at the company.
Andrew D. Ashe holds the position of Executive at Verve Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Andrew D. Ashe has shown a selling trading pattern, with $604.2K in total purchases and $2.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew D. Ashe was on Aug 3, 2015, when they sold $1.5M worth of DYAX shares. This transaction involved 62,320 shares at $24.21 per share.
Andrew D. Ashe currently owns 342,509 shares of Verve Therapeutics, Inc. (VERV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew D. Ashe's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew D. Ashe has 30 Form 4 filings on record as an insider at Verve Therapeutics, Inc..
Set alerts for Andrew D. Ashe and 40,000+ other insiders.